Results 121 to 130 of about 10,277 (200)

Radiotherapy plus neoadjuvant and concomitant IL-13Rα2-directed immunotoxin therapy for diffuse intrinsic pontine glioma. [PDF]

Commun Biol
Rechberger JS, Vanbilloen WJF, Nonnenbroich LF, Ge J, Schrecengost RS, Vaubel RA, Zhang L, Daniels DJ.   +7 more
europepmc   +1 more source

Folate Receptor: A Macrophage “Achilles' Heel”? [PDF]

, 2012
Hilgendorf, Ingo, Swirski, Filip K.
core   +1 more source

A new treatment for canine B-cell lymphoma based on a recombinant single-domain antibody immunotoxin derived from <i>Pseudomonas aeruginosa</i> exotoxin A. [PDF]

Front Vet Sci
André AS, Dias JNR, Moutinho I, Loureiro J, Leonardo A, Nogueira S, Marimon RP, Bule P, Correia J, Malhó R, Gano L, Correia JDG, Gil S, Gonçalves J, Pastan I, Tavares L, Aires-da-Silva F.   +16 more
europepmc   +1 more source

Assessment of the Effects of Single-Domain Anti-Idiotypic Distribution Enhancers on the Disposition of Trastuzumab and on the Efficacy of a PE24-Trastuzumab Immunotoxin. [PDF]

Cancers (Basel)
Chen P, Zhang Y, Bordeau BM, Balthasar JP.   +3 more
europepmc   +1 more source

Improving the cytotoxicity of immunotoxins by reducing the affinity of the antibody in acidic pH. [PDF]

J Transl Med, 2023
Liu X, Tan Q, Wen J, Wang X, Yang G, Li Y, Lu M, Ye W, Si A, Ma S, Ding T, Sun L, Liu F, Zhang M, Jiang T, Gao W.   +15 more
europepmc   +1 more source

J3ExoA: A Novel Anti-HIV Immunotoxin Fusion of Anti-Gp120 J3VHH and PE38 Fragment of <i>Pseudomonas</i> Exotoxin A. [PDF]

Pharmaceuticals (Basel)
Pincus SH, Luo K, Peters T, Gordy JT, Cole FM, Klug G, Ober K, Marcotte TK, Markham RB.   +8 more
europepmc   +1 more source

GrB-Fc-KS49, an anti-EMP2 granzyme B fusion protein therapeutic alters immune cell infiltration and suppresses breast cancer growth. [PDF]

J Immunother Cancer
Mohamedali KA, Aguirre B, Lu CH, Chandla A, Kejriwal N, Liu L, Chan AM, Cheung LH, Kok S, Duarte S, Alvarez de Cienfuegos A, Casero D, Rosenblum MG, Wadehra M.   +13 more
europepmc   +1 more source

Design and Characterization of Ricin Based Immunotoxins Against EPHA2 Receptor for Breast Cancer Therapy: An In-Silico Study. [PDF]

Iran J Pharm Res
Faraz A, Amani J, Arbabian S, Zare Karizi S, Bikhof Torbati M.   +4 more
europepmc   +1 more source

Recombinant anti-human epidermal growth factor receptor type 2 single-chain variable fragment-alpha-luffin fusion protein as a putative immunotoxin against human epidermal growth factor receptor type 2-positive breast cancer cells: an experimental research. [PDF]

Ann Med Surg (Lond), 2023
Damough S, Bayat E, Oghabi Bakhshaiesh T, Barkhordari F, Esmaeili R, Nematollahi L, Talebkhan Y.   +6 more
europepmc   +1 more source

Contempo 90: Transplantation [PDF]

, 1990
Fung, JJ, Starzl, TE
core